Occupier's Lunch - Clinical Trials

  • Wednesday, 31 March 2021, 1:00 PM to 2:00 PM
Share

Speakers:

Target2Treatment Consulting - Pauline Lukey, Managing Director

Pauline Lukey (Director and Founder) has extensive experience as an early development leader within the pharmaceutical industry (20 years); leading all aspects of projects from target identification, through candidate selection and first dose in humans up to clinical proof of concept. Her therapeutic expertise is in tuberculosis (8 years), rheumatoid arthritis (6 years) and fibrosis (6 years). She has led both small molecule and biopharm projects through discovery and early clinical development. She has an MSc in microbiology and genetics and a PhD in immunology. She is also a honorary senior lecturer in immunology at the London School of Hygiene and Tropical Medicine.

Exploristics - Aiden Flynn, CEO

Aiden Flynn is the founder and CEO of Exploristics and has 25 years’ experience as a statistician in drug discovery and clinical development. After seven years as a Lecturer at University College London, Aiden spent ten years at GlaxoSmithKline as a Director of Statistical Support for Biomarker Studies across research and development before founding Exploristics in 2009. At Exploristics, Aiden has created an innovative and profitable company and overseen its ongoing growth and transition from a specialist statistics consultancy to a provider of innovative specialist software with wrap-around biostatistics support. As such, Exploristics caters to a wide range of global healthcare developers from the world’s top pharmaceutical companies to biotechnology, medical device and diagnostic start-ups.

IQVIA - Christine Phillips 

IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare - and human health - forward. Together with the companies they serve, IQVIA are enabling a more modern, more effective and more efficient healthcare system, and creating breakthrough solutions that transform business and patient outcomes.

Agenda:

12:45-13:00 - Welcome from SBC

13:00-13:15 - Target2Treatment Consulting, 'Translational Science: what is it and why is it crucial'

13:15-13:30 - Exploristics

13:30-13:45 - IQVIA

13:45 - 14:00 - Discussion / Questions

Tickets here
Category:

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.